Why Do Western Governments Keep Folding to China? Nexperia Serves Up Another Example.
The Netherlands is the latest example of a country succumbing to China’s leadership position in critical supply chains.
Beef Prices: Blame the Packers, Not America’s Ranchers
KEY POINTS Beef prices are at record highs—not because of U.S. ranchers or tariffs, but because dependence on foreign imports and meatpacker consolidation have distorted
To Reshore Generic Drugs, Use Sugar’s Sweet Model
America is finally getting serious about its dangerous dependence on foreign-made generic drugs.
CPA Submits Section 232 Comments on Imports of Personal Protective Equipment, Medical Consumables, and Medical Equipment, Including Devices
The Trump administration’s section 232 investigation into medical devices and personal protective equipment is a vital step toward ensuring America takes back control over its production and domestic supply of critical medical products.
ICYMI: CPA Economist Andrew Rechenberg Stars at Hearing on Fixing America’s Broken Drug Supply Chain
The hearing continued the committee’s efforts to examine and reduce America’s severely dangerous over-dependence on foreign-manufactured generic drugs and address vulnerabilities in the nation’s pharmaceutical supply chain.
GM Tops the List of “Most Exposed to China”
This year, GM swapped positions with Ford. GM is the most exposed to China while Ford has declined to No. 5.
CPA’s Jeff Ferry Teaches the Next Generation How to Rebuild American Industry
CPA’s chief economist emeritus, Jeff Ferry, has gone back to school in his semi-retirement years. This time, though, it was a speaking gig at the University of Florida’s new Semiconductor Institute in Gainesville.
CPA Calls on Trump Administration to Take Strong, Decisive Action to Decouple from China and Strengthen U.S. Industrial Capacity
The era of global dependency on the CCP is over. For decades, Wall Street, multinational corporations, and globalist institutions helped finance China’s rise at the direct expense of American workers, manufacturers, and national security.
CPA Economist Leads Rare Bipartisan Push to Fix America’s Generic Drug Crisis
CPA Economist Andrew Rechenberg gave his testimony and answered questions in a four- panelist hearing. It was arguably the most agreeable hearing in years. A bipartisan consensus on America’s generic drug supply chain is nearly fully formed now.
New CPA Economic Report on ‘The New Biotech Cold War’
Titled “The New Biotech Cold War: The U.S. Medicine Can’t Afford to Fall Behind China,” the report shows how U.S. biotech – long a pillar of national strength – no longer has a guaranteed edge globally.
